Advertisement
Singapore markets closed

  • Straits Times Index

    3,301.02
    -13.03 (-0.39%)
     

  • S&P 500

    5,308.13
    +4.86 (+0.09%)
     

  • Dow

    39,806.77
    -196.82 (-0.49%)
     

  • Nasdaq

    16,794.88
    +108.91 (+0.65%)
     

  • Bitcoin USD

    70,963.01
    +4,140.74 (+6.20%)
     

  • CMC Crypto 200

    1,525.12
    +36.58 (+2.46%)
     

  • FTSE 100

    8,385.04
    -39.16 (-0.46%)
     

  • Gold

    2,423.00
    -15.50 (-0.64%)
     

  • Crude Oil

    79.16
    -0.64 (-0.80%)
     

  • 10-Yr Bond

    4.4370
    +0.0170 (+0.38%)
     

  • Nikkei

    38,946.93
    -122.75 (-0.31%)
     

  • Hang Seng

    19,220.62
    -415.60 (-2.12%)
     

  • FTSE Bursa Malaysia

    1,622.09
    -5.41 (-0.33%)
     

  • Jakarta Composite Index

    7,190.22
    -76.47 (-1.05%)
     

  • PSE Index

    6,633.66
    -49.12 (-0.74%)
     

INOVIO to Participate in Upcoming Investor Conferences in May

PR Newswire
·2-min read

PLYMOUTH MEETING, Pa., April 29, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced that management will participate in the following investor conferences during the month of May:

(PRNewsfoto/INOVIO Pharmaceuticals, Inc.)
(PRNewsfoto/INOVIO Pharmaceuticals, Inc.)

The Citizens JMP Life Sciences Conference
Date: Tuesday, May 14, 2024
Time: 11:30 AM ET
Presenter: Dr. Jacqueline Shea, President & CEO
Format: Fireside Chat

RBC Capital Markets 2024 Global Healthcare Conference
Date: Wednesday, May 15, 2024
Time: 10:00 AM ET
Presenter: Dr. Jacqueline Shea, President & CEO
Format: Fireside Chat

ADVERTISEMENT

H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
Date: Monday, May 20, 2024
Time: 12:30 PM ET
Presenter: Dr. Jacqueline Shea, President & CEO
Format: Fireside Chat

During the conferences, Dr. Shea and members of INOVIO's management team will conduct one-on-one meetings with registered investors.

Webcasts of the fireside chats will be available on the INOVIO Investor Relations Events page at https://ir.inovio.com/events-and-presentations/default.aspx. Replays of the webcasts will be available for 90 days after the date of the presentation.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

Contacts
Media: Jennie Willson (267) 429-8567 jennie.willson@inovio.com
Investors: Thomas Hong (267) 440-4298 thomas.hong@inovio.com

 

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-upcoming-investor-conferences-in-may-302129665.html

SOURCE INOVIO Pharmaceuticals, Inc.